Atherosclerosis and subsequent cardiovascular disease causes nearly one-third of all deaths in the world. Unfortunately, atherosclerosis commonly remains asymptomatic for decades, and is properly diagnosed only after a severe, life-threatening cardiac event. Thus, a portable, low‐cost tattoo‐based biosensor for the non‐invasive self‐diagnosis and quantification of atherosclerosis was developed.
In this study, the author engineers novel gelatin-NIPAM-graphene hydrogels and new, powerful computational tools to enhance precision cardiovascular medicine. Engineering Injectable, Conductive Hydrogels doped with Graphene and Graphene Oxide Nanoparticles for Post-MI Cardiac Tissue Engineering and Robust Drug Discovery: A Computationally-Aided Investigation for Enhancing Therapeutic Efficacy
Oral Squamous Cell Carcinoma (OSCC) is a cancer of the mouth epithelium with an annual incidence rate in the US of nearly 48,000 cases annually and a 5-year survival rate of only 65%. Cancer stem cells (CSCs) are believed to be responsible for progression of OSCC. The project’s main goal is to observe the effect of Wnt/β-catenin signaling inhibition on oral squamous cell carcinoma.
Wearable low power biometric devices and body sensor network systems (BSNs) such as heart, respiration, and activity monitors are popular devices that are predicted to increase tenfold by 2018. This project focused on biomechanical energy harvesting from rib cage expansion using piezoelectric materials and frequency up conversion to power wearable microelectronics.